Defective Ribosome Biogenesis Drives Tubular Senescence And Renal Fibrosis Via IRBC-P53 Activation
Our kidneys work tirelessly to filter waste, but sometimes they develop scarring, known as renal fibrosis, which can lead to chronic kidney disease. A recent study sheds light on a surprising culprit behind this scarring: problems with how cells make ribosomes. Ribosomes are like tiny factories within our cells that produce proteins, essential for all cellular functions. When the process of making these ribosomes goes awry, it triggers a cellular alarm system called the “impaired ribosome biogenesis checkpoint” (IRBC). This alarm, in turn, activates a crucial protein known as p53, often called the “guardian of the genome” because of its role in preventing abnormal cell growth. The activation of p53 then pushes kidney cells into a state of “senescence,” essentially an irreversible halt in cell division, which contributes to the scarring of kidney tissue. This research, using human kidney samples and experimental models, found that defects in ribosome production were present in scarred kidneys and that directly interfering with ribosome production could induce kidney scarring. Understanding this intricate pathway, from faulty ribosome production to cellular aging and kidney scarring, opens new avenues for developing treatments and diagnostic tools for chronic kidney disease, especially considering the use of certain drugs that can affect ribosome production.
Source: link to paper